ENO1 and Patent ductus arteriosus: Moreover, DNA vaccination targeting the overexpressed glycolytic enzyme alpha-enolase (ENO1), alone and much more in combination with CT or with MDSC inhibitor, efficiently delays tumor growth in vaccinated mice that spontaneously develop PDA (16–18).